Modus Therapeutics Holding AB
556851-9523ActiveSwedish biotech developing sevuparin for severe inflammatory conditions.
Biotechnology Companymodustx.com
Overview
- 1–4
- Employees
- 500–749K SEK
- Revenue
- 2011
- Founded
Description
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions. Their primary focus is the development of their proprietary polysaccharide, sevuparin. Sevuparin is being investigated as a potential therapeutic agent for several high unmet m...
Tags
B2BHolding CompanyTechnologyPharmaceuticals
Keywords
AnemiaBiotechnology